CVS HEALTH Corp
CVSNYSECIK 64803Consumer staplesFiscal year ends Dec 31
Reports and events: 372 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-01-0506:41 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-24-000009 |
| 2023-12-0506:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000064803-23-000049 |
| 2023-11-0106:38 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000064803-23-000047 |
| 2023-11-0106:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-23-000046 |
| 2023-10-1606:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-23-000994 |
| 2023-10-1317:22 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000064803-23-000040 |
| 2023-09-2107:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000947871-23-000948 |
| 2023-09-1116:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000064803-23-000036 |
| 2023-08-2316:22 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-23-000898 |
| 2023-08-1714:49 ET | 8-K | 7.01 Regulation FD disclosure | 0000947871-23-000871 |
| 2023-08-0206:36 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000064803-23-000033 |
| 2023-08-0206:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-23-000032 |
| 2023-07-2016:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000947871-23-000769 |
| 2023-06-0216:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-159832 |
| 2023-06-0118:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-158071 |
| 2023-05-3106:28 ET | 8-K | 7.01 Regulation FD disclosure | 0000064803-23-000024 |
| 2023-05-2506:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000064803-23-000021 |
| 2023-05-2417:17 ET | 8-K | 5.07 Shareholder vote results | 0000064803-23-000019 |
| 2023-05-0306:38 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000064803-23-000016 |
| 2023-05-0306:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-23-000015 |
| 2023-05-0216:09 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 2.04 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0000947871-23-000511 |
| 2023-04-0716:00 ET | DEF 14A | Proxy statement | 0001308179-23-000606 |
| 2023-03-3007:46 ET | 8-K | 7.01 Regulation FD disclosure | 0000947871-23-000398 |
| 2023-02-2116:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-043484 |
| 2023-02-1516:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-040200 |
| 2023-02-0817:28 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000947871-23-000139 |
| 2023-02-0806:37 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000064803-23-000009 |
| 2023-02-0806:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-23-000008 |
| 2023-02-0806:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-23-000133 |
| 2023-01-2316:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-23-000080 |
| 2023-01-0906:27 ET | 8-K | 2.02 Results of operations | 0000064803-23-000003 |
| 2022-11-2116:34 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000947871-22-001199 |
| 2022-11-0206:36 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000064803-22-000038 |
| 2022-11-0206:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-22-000037 |
| 2022-10-2006:45 ET | 8-K | 8.01 Other events | 0001193125-22-265682 |
| 2022-10-0617:02 ET | 8-K | 8.01 Other events | 0000947871-22-001055 |
| 2022-09-1306:55 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000947871-22-000962 |
| 2022-09-1306:30 ET | 8-K | 7.01 Regulation FD disclosure | 0000064803-22-000032 |
| 2022-09-0606:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-238311 |
| 2022-09-0606:14 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-238304 |
| 2022-08-0306:35 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000064803-22-000029 |
| 2022-08-0306:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-22-000028 |
| 2022-08-0216:10 ET | 8-K | 8.01 Other events | 0000947871-22-000819 |
| 2022-07-1516:22 ET | 8-K | 8.01 Other events | 0000947871-22-000785 |
| 2022-06-0906:32 ET | 8-K | 7.01 Regulation FD disclosure | 0000064803-22-000021 |
| 2022-05-1616:40 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000064803-22-000018 |
| 2022-05-1616:27 ET | 8-K | 8.01 Other events | 0000947871-22-000596 |
| 2022-05-0406:35 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000064803-22-000016 |
| 2022-05-0406:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-22-000015 |
| 2022-04-0116:32 ET | DEF 14A | Proxy statementPeriod 2022-05-11 | 0001206774-22-000965 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.